Tech Company Financing Transactions

Octave Bioscience Funding Round

Octave Bioscience secured a $35.6 million Series C funding round on 9/5/2025. Investors included Blue Venture Funds, Byers Capital and Casdin Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

1440 O'Brien Dr. B
Menlo Park, CA 94025
USA

Phone

(650) 233-2750

Website

www.octavebio.com

Email Address

[email protected]

Overview

Octave is developing a comprehensive, first-in-class Care Management Platform. Our team has developed novel measurement tools that feed into structured analytical data models, leading to improved decision-making, better outcomes, and lower costs. We're tackling neurodegenerative diseases -- starting with multiple sclerosis (MS).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

William Hagstrom

        

Chief Operating Officer

Melinda Thomas

        

Chief Technical Officer

Erwan Rivet

        

VP - Bus. Development

Maital Shemesh-Rasmussen

        

Browse more venture capital transactions:

Prev: 9/4/2025: Recall.ai venture capital transaction
Next: 9/5/2025: Elysian venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary